Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $6.34 down -9.04% from its previous closing price of $6.97. In other words, the price has decreased by -$9.04 from its previous closing price. On the day, 3.63 million shares were traded.
Ratios:
For a deeper understanding of Capricor Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.77 and its Current Ratio is at 7.77. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on October 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On May 17, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.
On January 05, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.Cantor Fitzgerald initiated its Overweight rating on January 05, 2024, with a $8 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 13.00 while its Price-to-Book (P/B) ratio in mrq is 1.99.
Stock Price History:
Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is -44.52%, while the 200-Day Moving Average is calculated to be -48.96%.
Shares Statistics:
A total of 45.58M shares are outstanding, with a floating share count of 40.12M. Insiders hold about 12.16% of the company’s shares, while institutions hold 37.24% stake in the company.
Earnings Estimates
The current market rating for Capricor Therapeutics Inc (CAPR) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.18 and low estimates of -$0.4.
Analysts are recommending an EPS of between $1.63 and -$1.39 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.07, with 5.0 analysts recommending between $1.37 and -$1.28.
Revenue Estimates
Based on 7 analysts’ estimates, the company’s revenue will be $108.19M in the next fiscal year. The high estimate is $259.35M and the low estimate is $40M.
